XML 22 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
SEGMENT INFORMATION
 3 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
SEGMENT INFORMATION
5.
SEGMENT INFORMATION
 
We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to Consolidated Financial Statements in our annual report on Form 10-K for the fiscal year ended September 30, 2018.
 
 
 
Three Months Ended

December 31,
 
 
 
2018
 
 
2017
 
Revenue:
 
 
 
 
 
 
Service
 
$
7,735
 
 
$
4,525
 
Product
 
 
890
 
 
 
852
 
 
 
$
8,625
 
 
$
5,377
 
Operating income (loss):
 
 
 
 
 
 
 
 
Service
 
$
215
 
 
$
182
 
Product
 
 
(175
)
 
 
(171
)
 
 
$
41
 
 
$
11
 
 
 
 
 
 
 
 
 
 
Interest expense
 
 
(126
)
 
 
(52
)
Other income
 
 
1
 
 
 
—
 
Loss before income taxes
 
$
(84
)
 
$
(41
)